Hallmarks of Cancer welcomes Dr. Natasha Kyprianou
Dr. Natasha Kyprianou, second from left, is presented a watercolor print of the Medical Center. Welcoming her are, from left, Dr. Jawed Siddiqui, assistant professor of cell and molecular biology; Dr. Seema Singh, CCRI associate director of education and training; and Dr. Ajay Singh, CCRI associate director of basic and translational research.
The first Hallmarks of Cancer lecture in 2026 featured Dr. Natasha Kyprianou, professor and vice chair for basic science research in urology at Icahn School of Medicine at Mount Sinai. An internationally recognized leader in prostate cancer research, her work focuses on TGF-β signaling, therapeutic resistance and novel treatments. She has authored more than 400 publications and mentored numerous trainees.
The title of her presentation was “Phenotypic Reprogramming Overcomes Therapeutic Resistance in Advanced Prostate Cancer.”
